During the past decade, Institut de recherches cliniques de Montréal conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 7 clinical trials were completed, i.e. on average, 10.6% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 5 clinical trials were completed. i.e. 13.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut de recherches cliniques de Montréal" #1 sponsor was "Institut de Recherches Cliniques de Montreal" with 48 trials, followed by "Arrowhead Pharmaceuticals" with 4 trials sponsored, "McGill University" with 4 trials sponsored, "Amgen" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut de recherches cliniques de Montréal" #1 collaborator was "Institut de Recherches Cliniques de Montreal" with 7 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 5 trials as a collaborator, "McGill University" with 5 trials as a collaborator, "Montreal Children's Hospital of the MUHC" with 5 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 4 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Institut de recherches cliniques de Montréal" are "Type 1 Diabetes" (28 trials), "Cystic Fibrosis" (8 trials), "Type 1 Diabetes Mellitus" (7 trials), "Type 2 Diabetes" (7 trials) and "Hypertension" (4 trials). Many other conditions were trialed in "Institut de recherches cliniques de Montréal" in a lesser frequency.

Most popular intervention types in "Institut de recherches cliniques de Montréal" are "Other" (42 trials), "Drug" (38 trials), "Device" (20 trials), "Behavioral" (6 trials) and "Dietary Supplement" (6 trials). Other intervention types were less common.

The name of intervention was led by "Insulin" (11 trials), "Placebo" (11 trials), "Insulin pump" (5 trials), "ARO-APOC3" (4 trials) and "Dexcom G4 Platinum glucose sensor" (4 trials). Other intervention names were less common.

The vast majority of trials in "Institut de recherches cliniques de Montréal" are 82 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Institut de recherches cliniques de Montréal". undefined are not yet recruiting, 17 are recruiting, 8 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 46 completed trials in Institut de recherches cliniques de Montréal, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Institut de recherches cliniques de Montréal, 3 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 27 trials that are defined as “Not Applicable".